|
Maternal characteristics
|
|
Site, n (%)
|
|
Migrant
|
464 (33.9)
|
60 (28.3)
|
1
|
0.107
|
–
|
–
|
|
Refugee
|
904 (66.1)
|
152 (71.7)
|
1.3 [0.9–1.8]
| |
–
| |
|
Ethnicity, n (%)
|
|
Karen
|
1014/1348 (75.2)
|
151/198 (76.3)
|
1
|
0.434
|
–
|
–
|
|
Burman
|
230/1348 (17.1)
|
28/198 (13.2)
|
0.8 [0.5–1.2]
| |
–
|
–
|
|
Other
|
104/1348 (7.7)
|
19/198 (9.0)
|
1.2 [0.7–2.1]
| |
–
|
–
|
|
Age in years, median, (IQR)
|
24 (20–30)
|
23 (20–31)
|
1.0 [0.9–1.0]
|
0.777
|
–
|
–
|
|
Literacy, n (%)
|
846/1280 (66.1)
|
101/162 (62.3)
|
0.9 [0.6–1.2]
|
0.347
|
–
|
–
|
|
Smoking, n (%)
|
189/1364 (13.9)
|
33/210 (15.7)
|
1.2 [0.8–1.7]
|
0.477
|
–
|
–
|
|
Primigravida, n (%)
|
668 (48.8)
|
95 (44.8)
|
0.9 [0.6–1.1]
|
0.276
|
–
|
–
|
|
Multiple pregnancy, n (%)
|
52 (3.8)
|
9 (4.2)
|
1.1 [0.5–2.3]
|
0.758
|
–
|
–
|
|
Place of birth, n (%)
|
|
SMRU
|
1241 (90.7)
|
182 (85.8)
|
1
|
0.011
|
–
|
–
|
|
Tertiary hospital
|
61 (4.5)
|
7 (3.3)
|
0.8 [0.4–1.7]
| |
–
|
–
|
|
Home
|
58 (4.2)
|
19 (9.0)
|
2.2 [1.3–3.8]
| |
–
|
–
|
|
Other
|
8 (0.6)
|
4 (1.9)
|
3.4 [1.0–11.4]
| |
–
|
–
|
|
Breech and face delivery, n (%)
|
36 (2.6)
|
13 (6.1)
|
2.4 [1.3–4.6]
|
0.008
|
2.0 [1.0–4.3]
|
0.056
|
|
Instrumental vaginal delivery, n (%)
|
58 (4.4)
|
4 (1.9)
|
0.4 [0.2–1.2]
|
0.073
|
–
|
–
|
|
Newborn characteristics
|
|
Gender (male), n (%)
|
796 (58.2)
|
126 (59.7)
|
1.1 [0.8–1.4]
|
0.731
|
–
|
–
|
|
Small for gestational age, n (%)
|
251/1350 (18.6)
|
46/204 (15.5)
|
1.3 [0.9–1.8]
|
0.188
|
1.3 [0.9–2.0]
|
0.139
|
|
Gestational age, n (%)
|
|
< 32 weeks
|
38/1367 (2.8)
|
15/211 (7.1)
|
3.5 [1.9–6.5]
|
< 0.001
|
3.3 [1.6–6.6]
|
< 0.001
|
|
32 < 37 weeks
|
352/1367 (25.7)
|
85/211 (40.3)
|
2.1 [1.6–2.9]
|
2.2 [1.6–3.1]
|
|
≥ 37 weeks
|
977/1367 (71.5)
|
111/211 (52.6)
|
1
|
1
|
|
Congenital abnormality, n (%)
|
34 (2.5)
|
10 (4.7)
|
1.9 [1.0–4.0]
|
0.089
|
2.4 [1.1–5.3]
|
0.027
|
|
G6PD deficiency, n (%)
|
213/1364 (15.6)
|
54 (25.5)
|
1.9 [1.3–2.6]
|
< 0.001
|
2.3 [1.6–3.3]
|
< 0.001
|
|
Potential ABO incompatibility, n (%)
|
238/1341 (17.7)
|
45/205 (22.0)
|
1.3 [0.9–1.9]
|
0.155
|
1.5 [1.0–2.2]
|
0.032
|
|
INH as sole clinical diagnosis, n (%)
|
814 (59.5)
|
97 (45.8)
|
1.7 [1.3–2.3]
|
< 0.001
|
–
|
–
|
|
Infection, n (%)
|
|
No infection associated
|
955 (69.8)
|
123 (58.0)
|
1
|
0.003
|
1
|
0.006
|
|
Associated severe infection
|
240 (17.5)
|
56 (26.4)
|
1.8 [1.3–2.6]
| |
1.8 [1.2–2.7]
| |
|
Associated mild infection
|
173 (12.6)
|
33 (15.6)
|
1.5 [0.9–2.3]
| |
1.4 [0.9–2.2]
| |
|
Age at presentation, n (%)
|
|
0–24 h
|
154 (11.3)
|
37 (17.5)
|
2.1 [1.4–3.3]
|
< 0.001
|
1.5 [0.9–2.4]
|
0.003
|
|
> 24–72 h
|
160 (55.6)
|
85 (40.1)
|
1
| |
1
| |
|
> 72 h
|
454 (33.2)
|
90 (42.5)
|
1.8 [1.3–2.4]
| |
1.8 [1.3–2.6]
| |
|
Length of phototherapy in hours, median, (IQR)
|
36 (22–66)
|
72 (43–133)
|
–
|
< 0.001
|
–
| |
|
Mortality during hospitalization, n, (%)
|
14 (1.0)
|
17 (8.0)
|
8.4 [4.1–17.4]
|
< 0.001
|
–
|
–
|
